palmoplantar keratosis
Recently Published Documents


TOTAL DOCUMENTS

58
(FIVE YEARS 14)

H-INDEX

9
(FIVE YEARS 1)

2021 ◽  
Vol 8 ◽  
Author(s):  
Giovanni Innella ◽  
Elena Bonora ◽  
Iria Neri ◽  
Annalucia Virdi ◽  
Alba Guglielmo ◽  
...  

Germline PTEN pathogenic variants cause a spectrum of disorders collectively labeled PTEN Hamartoma Tumor Syndrome (PHTS) and featured by hamartomas, developmental anomalies and increased cancer risk. Studies on experimental models provided evidence that PTEN is a “haploinsufficient” tumor-suppressor gene, however, mechanisms involved in the pathogenesis of clinical manifestations in PHTS patients remain elusive. Beyond analyzing clinical and molecular features of a series of 20 Italian PHTS patients, we performed molecular investigations to explore the mechanisms involved in the pathogenesis of PTEN-associated manifestations, with special focus on mucocutaneous manifestations. Typical mucocutaneous features were present in all patients assessed, confirming that these are the most important clue to the diagnosis. The most frequent were papules located in the trunk or extremities (73.7%), oral mucosa papules (68.4%), acral/palmoplantar keratosis and facial papules (both 57.9%), according with literature data. Molecular analyses on one trichilemmoma suggested that the wild-type PTEN allele was retained and expressed, reinforcing the evidence that PTEN does not require a second somatic hit to initiate pathogenic processes. Unexpectedly, one patient also displayed a cutaneous phenotype consistent with atypical mole/melanoma syndrome; no variants were detected in known melanoma genes, but Whole Exome Sequencing showed the rare truncating variant c.495G>A in the CDH13 gene that might have cooperated with PTEN-haploinsufficiency to generate such phenotype. Our findings confirm the reproducibility of known PHTS manifestations in real-world practice, highlighting the role of mucocutaneous manifestations in facilitating prompt diagnosis of the syndrome, and provide some insights into the pathogenic process induced by PTEN alterations, which may contribute to its understanding.


Author(s):  
Kajal Patel ◽  
Alex Gin ◽  
Laura Scardamaglia

2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
Chao Huang ◽  
Yali Yang ◽  
Xingyu Huang ◽  
Zongke Zhou

Nagashima-type palmoplantar keratosis (NPPK) is the most prevalent palmoplantar keratoderma (PPK) in East Asia. Homozygous or compound heterozygous loss-of-function mutations in serpin peptidase inhibitor, clade B (ovalbumin), and member 70 (SERPINB7), which encodes members of the serine protease inhibitor superfamily, have been identified as the cause of NPPK. Clinical manifestations of NPPK include well-demarcated erythema, mild to moderate hyperkeratosis on the whole palm, and sole with transgrediens, extending to the dorsal surfaces of the hands and feet, inner wrists, ankles, and the Achilles tendon areas. In this study, we perform a review of relevant clinical cases aimed at elucidating the clinical characteristics, genetic characterization, differential diagnoses, and clinical management of NPPK. A better understanding of the clinical characteristics and pathogenic gene characterization of NPPK will enhance the diagnosis of NPPK, identify related diseases, and inform on the precise therapy and prognosis. Moreover, it will promote the awareness of NPPK in non-Asian regions.


2021 ◽  
Vol 101 (2) ◽  
pp. adv00392
Author(s):  
Y Li ◽  
X Yu ◽  
C Pan ◽  
Y Wang ◽  
J Han ◽  
...  

2020 ◽  
Vol 12 (3) ◽  
pp. 241-248
Author(s):  
Chankiat Songsantiphap ◽  
Jirat Suwanwatana ◽  
Chupong Ittiwut ◽  
Pravit Asawanonda ◽  
Pawinee Rerknimitr ◽  
...  

Nagashima-type palmoplantar keratosis (NPPK) is a diffuse, non-syndromic (isolated), autosomal recessive palmoplantar keratoderma (PPK) with transgredients. It is characterized by non-progressive mild to moderate transgredient PPK. The mutation in <i>SERPINB7</i> is reported to underlie the condition. Though many case reports/series have demonstrated various mutations in <i>SERPINB7</i>, the genotype-phenotype correlation in this disorder is still lacking. We herein report two brothers with NPPK. Both patients were found to be compound heterozygous for c.796C&#x3e;T and c.650_653delCTGT in the <i>SERPINB7</i> gene. We then summarize the previously reported cases of different mutations in <i>SERPINB7</i> along with their clinical phenotypes in an attempt to shed some light on this correlation. Further investigations and systematic data collection are still needed to clarify this issue.


2020 ◽  
Vol 47 (12) ◽  
Author(s):  
Michitaro Hayakawa ◽  
Umi Tahara ◽  
Noriko Ono ◽  
Satomi Aoki ◽  
Tomoko Kawai ◽  
...  

2020 ◽  
Vol 83 (2) ◽  
pp. 643-645
Author(s):  
Katariina Hannula-Jouppi ◽  
Liisa Harjama ◽  
Elisabet Einarsdottir ◽  
Outi Elomaa ◽  
Kaisa Kettunen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document